Iqvia Holdings (IQV) Long-Term Investments (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Long-Term Investments came in at $390.0 million in Q2 2026, up 43.38% year-over-year from $272.0 million in Q2 2025, and up 9.24% quarter-over-quarter from $357.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Long-Term Investments (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Long-Term Investments across 15 years of filings, most recently posting $390.0 million for Q2 2026.
- In Q2 2026, Long-Term Investments rose 43.38% year-over-year to $390.0 million; the TTM figure through Jun 2026 stood at $390.0 million (up 43.38% YoY), while the FY2025 annual figure was $324.0 million, up 21.8% from the prior year.
- Long-Term Investments came in at $390.0 million for Q2 2026 at Iqvia Holdings, up from $357.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $390.0 million in Q2 2026 to a low of $87.0 million in Q3 2022.
- Average Long-Term Investments over 5 years is $194.1 million, with a median of $167.5 million recorded in 2024.
- Year-over-year, Long-Term Investments advanced 2.27% in 2022 and jumped 98.51% in 2024.
- Over 5 years, Long-Term Investments stood at $94.0 million in 2022, then surged by 42.55% to $134.0 million in 2023, then jumped by 98.51% to $266.0 million in 2024, then climbed by 21.8% to $324.0 million in 2025, then advanced by 20.37% to $390.0 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $390.0 million in Q2 2026, $357.0 million in Q1 2026, and $324.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 390.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 107.23 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 206.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 4.04 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 14.78 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 390.00 Mn |
| Mar 31, 2026 | 357.00 Mn |
| Dec 31, 2025 | 324.00 Mn |
| Sep 30, 2025 | 275.00 Mn |
| Jun 30, 2025 | 272.00 Mn |
| Mar 31, 2025 | 253.00 Mn |
| Dec 31, 2024 | 266.00 Mn |
| Sep 30, 2024 | 203.00 Mn |
| Jun 30, 2024 | 181.00 Mn |
| Mar 31, 2024 | 154.00 Mn |
| Dec 31, 2023 | 134.00 Mn |
| Sep 30, 2023 | 115.00 Mn |
| Jun 30, 2023 | 107.00 Mn |
| Mar 31, 2023 | 99.00 Mn |
| Dec 31, 2022 | 94.00 Mn |
| Sep 30, 2022 | 87.00 Mn |
| Jun 30, 2022 | 92.00 Mn |
| Mar 31, 2022 | 90.00 Mn |
| Dec 31, 2021 | 88.00 Mn |
| Sep 30, 2021 | 84.00 Mn |